Advancements Transforming the US Oral Thin Film Drugs Market Landscape
The US oral thin film drugs market is on track to reach an estimated value of $900 million by 2025, with projections soaring to approximately $1.935 billion by 2035. This market is currently valued at $789.55 million and is expanding at a compound annual growth rate (CAGR) of 7.76%. This growth trajectory is fueled by technological advancements and an increasing demand for non-invasive drug...
0 Comments 0 Shares 94 Views 0 Reviews